Here at MOST, it is our innate responsibility to bring forth continuous innovation, and to support our national contingency measures against the coronavirus outbreak using the most advanced technologies.

For over 17 years, MOST has been working ceaselessly on epidemic prevention since the SARS outbreak in 2003. Among series of measures, specialized project was set up to provide funds to over 150 national labs and scientists on infectious diseases related researches. In addition, MOST continued to strengthen project structure and increase funding for more than 10 labs during the periods of serious outbreaks, such as avian influenza virus, dengue virus, and enterovirus.

MOST’s strong R&D power, outstanding basic science research foundation and accumulated experience on infectious diseases have greatly contributed to Taiwan’s effective epidemic on treatment and vaccine development, and the discovery of faster diagnostic test method.

Amid the ongoing outbreak, the dedication of MOST along with our research institutions and scientists have made tremendous accomplishments, including the promotion of general education on public health and epidemic prevention, the replication of Remdesivir, the isolation of virus strain, and the development of antibodies for coronavirus. These breakthroughs have undoubtedly proved that technology plays a critical role in supporting our nation’s battle against the current pandemic.

Aside from the epidemic control effort, MOST also prioritizes several key missions in the development of green and sustainable technologies. In this issue, we featured numerous exciting new researches, such as the CO₂ reduction technology, a Subtropical Performance Test Bed for Innovative eNergy Research in Building (the SPIN Lab), sustainable hydrogen production, a microgrid with a virtual inertia design, and innovative research for battery safety and efficiency. Join us in exploring more of the amazing works done by some of Taiwan’s respected experts in the related fields.